Propiedad y actividad de insiders de Moleculin Biotech, Inc. (MBRX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.74 |
| Capitalización | $4M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.0M | $7.7M | $7.1M | $10.7M | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | $8.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $56000 | $11000 | $1000 | $45000 | 0 | 0 | 0 | $7000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $5.2M | $8.3M | $8.0M | $13.5M | $17.2M | $72.5M | $45.6M | $26.3M | $5.2M | $9.7M |
| Inmovilizado Material | $23128 | $33000 | $463000 | $603000 | $685000 | $445000 | $678000 | $796000 | $583000 | $314000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M |
| Activos Totales | $16.4M | $19.5M | $19.6M | $25.2M | $29.2M | $84.1M | $57.4M | $38.2M | $16.9M | $22.1M |
| Cuentas por Pagar | $399000 | $810000 | $1.2M | $2.2M | $1.1M | $1.4M | $2.1M | $2.5M | $2.0M | $3.5M |
| Deuda a Corto | $296000 | 0 | 0 | $103000 | $118000 | $96000 | 0 | 0 | 0 | $137000 |
| Pasivos Corrientes | $1.3M | $2.2M | $3.9M | $3.6M | $2.9M | $3.6M | $4.8M | $6.8M | $5.4M | $6.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.4M | $2.4M | $5.3M | $9.7M | $11.3M | $5.1M | $5.2M | $12.1M | $10.9M | $7.1M |
| Reservas | -$4.7M | -$14.5M | -$26.4M | -$39.6M | -$56.9M | -$72.8M | -$101.8M | -$131.6M | -$153.4M | -$206.0M |
| Patrimonio Neto | $15.0M | $17.1M | $14.3M | $15.6M | $17.9M | $79.0M | $52.2M | $26.1M | $6.0M | $15.0M |
| Deuda Total | $296412 | 0 | 0 | $379000 | $277000 | $159000 | $451000 | $574000 | $478000 | $359000 |
| Deuda Neta | -$4.7M | -$7.7M | -$7.1M | -$10.4M | -$14.9M | -$70.7M | -$42.7M | -$23.0M | -$3.8M | -$8.5M |
| Capital Circulante | $3.9M | $6.1M | $4.1M | $9.9M | $14.3M | $68.9M | $40.8M | $19.5M | -$165000 | $2.8M |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 0.94 |
Rentabilidad
| Rentabilidad sobre capital | -816.56% |
| Rentabilidad sobre capital invertido | -242.25% |
| Rentabilidad sobre activos | -143.82% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ADAP · AIMD · APLM · ATHA · BLRX · CTXR · ICU
Explorar sector: Healthcare · Biotechnology
Más secciones de MBRX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones